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Protein kinaseomplex signaling pathways to achieve cytoplasmic and nuclear competencies for
fertilization and development. The Src-family kinases FYN, YES and SRC are expressed in mammalian oocytes
but their function during oocyte maturation remains an open question. Using chemical inhibitor, siRNA
knockdown, and gene deletion strategies the function of Src-family kinases was evaluated in mouse oocytes
during maturation under in vivo and in vitro conditions. Suppression of Src-family as a group with SKI606
greatly reduced meiotic cell cycle progression to metaphase-II. Knockdown of FYN kinase expression after
injection of FYN siRNA resulted in an approximately 50% reduction in progression to metaphase-II similar to
what was observed in oocytes isolated from FYN (−/−) mice matured in vitro. Meiotic cell cycle impairment
due to a Fyn kinase deﬁciency was also evident during oocyte maturation in vivo since ovulated cumulus
oocyte complexes collected from FYN (−/−) mice included immature metaphase-I oocytes (18%).
Commonalities in meiotic spindle and chromosome alignment defects under these experimental conditions
demonstrate a signiﬁcant role for Fyn kinase activity in meiotic maturation.
© 2008 Elsevier Inc. All rights reserved.Introduction
Mammalian oocytes acquire essential properties for fertilization
and early development as they mature coincident with the process of
ovulation. Meiotic maturation is elicited in vivo by the periovulatory
LH surge and encompasses a series of events that occur over a time
span of hours in rodents to days in the case of humans and other
mammalian species (Edwards, 1965). While it has long been
recognized that mammalian oocytes proceed from prophase-I arrest
(GV) through to metaphase-II (MII) when removed from the
inhibitory environment of the ovarian follicle (Cho et al., 1974),
there is an emerging notion that a complex signaling dialogue
between companion granulosa cells and oocytes modulates the
reinitiation, progression, and arrest of meiosis at metaphase-II. Thus,
original studies invoking cAMP and protein kinase A (PKA) signaling
and communication between the oocyte and cumulus granulosa cells
(Anderson and Albertini, 1976; Cho et al., 1974; Eppig et al., 1983;
Lindner et al., 1974; Schultz et al., 1983) appear as oversimpliﬁcations
since recent studies have identiﬁed a complex multifactorial sequence
of signaling effectors to be operative (Zhang et al., 2007). Speciﬁcally,
reception of LH inmural granulosa cells, at least in rodents, is followedAMP, Dibutyryl cAMP; GVBD,
MI, Meiosis-I; MII, Meiosis-II;
protein tyrosine kinase.
is).
l rights reserved.by de novo production of EGF family ligands that drive the reinitiation
of meiosis. At the level of the oocyte, mechanisms involving selective
inactivation of oocyte phosphodiesterases leading to decreased cAMP
and PKA activities within the oocyte appear linked to a rise in Cdk1/
cyclinB and p44/42 MAPK supporting meiotic maturation from the GV
to metaphase-II stages (Eppig et al., 1983; Liang et al., 2007;
Mehlmann et al., 2006; Panigone et al., 2008).
Of the pathways recently implicated in oocyte maturation and egg
activation in mammals are those involving Src-family protein tyrosine
kinases (SFKs) (McGinnis et al., 2007; Mehlmann and Jaffe, 2005;
Meng et al., 2006; Talmor-Cohen et al., 2004a; Zheng et al., 2007).
Src-family kinases are a family of nine closely related protein tyrosine
kinases of which three (FYN, YES and sometimes SRC) have been
identiﬁed in mammalian oocytes (Mehlmann and Jaffe, 2005; Meng
et al., 2006; Talmor-Cohen et al., 2004a; Talmor et al., 1998). The
involvement of Src-family signaling pathways in mammalian oocyte
maturation was shown by in vitro maturation studies in mouse
oocytes where the SFK inhibitor PP2 blocked germinal vesicle
breakdown (GVBD) (Zheng et al., 2007). Src-family kinases localize
to the region of the meiotic metaphase-II spindle and Fyn kinase
co-precipitates with tubulin from egg cytoplasm (McGinnis et al.,
2007; Meng et al., 2006; Talmor-Cohen et al., 2004b; Talmor et al.,
1998) further implicating participation of SFKs in meiotic spindle
function. An idea supported by the fact that aged rat oocytes undergo
meiotic spindle disruption in the presence of SFK inhibitors (PP2 or
SU6656) (Talmor-Cohen et al., 2004b). Moreover, while chemical
inhibition of SFKs during fertilization of mouse oocytes permitted
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mitotic cell cycle were inhibited in association with severe abnorm-
alities in spindle microtubule organization and chromosome align-
ment (McGinnis et al., 2007). Since injection of a constitutively active
form of Fyn into MII rat oocytes caused egg activation, metaphase–
anaphase transition and extrusion of the second polar body (Talmor-
Cohen et al., 2004b) these studies collectively implicate SFKs in
microtubule dynamics and cell cycle progression in the mature
mammalian oocyte and fertilized egg. The rather limited evidence
implicating SFKs in earlier stages of meiotic maturation of mammalian
oocytes prompted the present investigation into the role of SFKs in
meiotic cell cycle progression in mouse oocytes with reference to
meiotic spindle morphogenesis and functionality.
Materials and methods
Oocyte collection
Cumulus–Oocyte-Complexes (COC) were collected from 6–7 week
old female mice. Most experiments used CF1 female mice (Harlan
Sprague–Dawley, Indianapolis IN or Charles River Laboratories,
Wilmington MA). FYN knock-out mice (B6/129S7-Fyntm1Sor/J; FYN
(−/−) (Stein et al., 1992)) and the recommended control (B6/129SF2/J)
mice were purchased from Jackson Laboratories (Bar Harbor, ME) and
a homozygous knock-out colony was maintained at the University of
Kansas Medical Center. Mice were housed in a temperature and light-
controlled room on a 14L:10D light cycle and experiments were
conducted in accordance with the Guide for the Care and Use of
Laboratory Animals (National Academy of Sciences 1996). Mice were
euthanized by isoﬂuorothane inhalation anesthesia followed by
cervical dislocation. Females were stimulated with 5 IU equine
chorionic gonadotropin (eCG; Calbiochem, San Diego CA). Ovaries
were collected at 42–46 h post-eCG. COC were released from large
antral follicles into HEPES-buffered KSOM (FHM, Chemicon-Millipore,
Billerica MA) with 4 mg/ml BSA (mFHM). For experiments in which
ovulated oocytes were used, female mice were stimulated with 5 IU
eCG followed 48 h later with 5 IU human chorionic gonadotropin
(hCG) and ovulated oocytes were collected from the oviducts 15–16 h
post-hCG. For experiments examining the effects of chemical
inhibitors of Src kinases, COC were released from the ovary directly
into mFHM containing the ﬁnal concentration of the inhibitor
treatment, then transferred directly into maturation medium supple-
mented with the same concentration of the chemical inhibitors. Prior
to release of COCs, each ovary was cut into 2 pieces and the 4 ovarian
pieces from each donor female were allocated to different treatments.
In other experiments, COC were released into media without Src
inhibitor, with or without 300 μM cAMP according to the individual
experimental protocol (see below). While most experiments were
conducted with KSOM-MAT (see below) as a semi-deﬁned culture
medium, in vitro maturation media for the FYN −/− and their control
COC were supplemented with 5% fetal bovine serum to provide
optimum conditions for cumulus expansion. In experiments that used
oocytes without cumulus cells, COC were collected as stated then
cumulus cells manually removed by repeated pipetting with a pulled
glass pipette.
Pharmacological treatment of oocytes
To test the effects of Src-family PTK chemical inhibitor on meiosis,
oocytes with or without their companion cumulus cells were cultured
for 16–17 h in KSOM-MAT (KSOMAA (Chemicon-Millipore, Billerica
MA (Biggers et al., 2000))) supplemented with 5 mM glucose (Biggers
and McGinnis, 2001), 1 mM glycyl-glutamine, 0.23 mM pyruvate,
4 mg/ml BSA, 0.6 mM L-cysteine, 0.5 mg/ml D-glucosamine, 0.02 μM
ascorbate, 1% insulin–transferrin–selenium (ITS), 0.2 IU/ml recombi-
nant human FSH (Serono Reproductive Biological Institute) and 10 ng/ml EGF Calbiochem, San Diego CA). SKI606 (Calbiochem, San Diego
CA) was prepared as 10mM stock solution in DMSO and stored −20 °C.
Media were prepared fresh on the day of oocyte collection and pre-
equilibrated in a humidiﬁed (6%CO2, 5%O2 and 89%N2) incubator
(Sanyo) for at least 2 h before oocyte culture. Denuded oocytes were
matured in groups of b10 per well in 60-well NUNC Terasaki plates
with 10.5 μl medium over layered with 3 μl oil (0.22 μm sterile ﬁltered
Sigma Embryo Tested Mineral Oil stored in the dark; cat. M8410).
Intact COC were cultured in 30–50 μl drops covered with oil in NUNC
4-well plates. After 16–17 h in vitro maturation, oocytes were ﬁxed for
labeling and confocal image analysis.
Fixation and immunohistochemical staining
Methods for ﬁxation and immunohistochemistry were similar to
those previously reported (McGinnis et al. 2007). Brieﬂy, oocytes and
COC were ﬁxed for 10 min at room temperature in FHMmediumwith
3% paraformaldehyde followed by 30 min at 35 °C in 2% formaldehyde
inmicrotubule stabilizationbuffer (MTSB-XF (Messinger andAlbertini,
1991)). After ﬁxation, COC were transferred into wash solution
(McGinnis et al. 2007) and held overnight at 4 °C. All ﬁxatives and
wash solutions were supplemented with 40 μM phenylarsine oxide,
100 μM sodium orthovanadate and 10 μM okadaic acid to inhibit
phosphatase activity. Antibodies used included Clone 28 antibody
(Biosource International, Camarillo CAUSA) to localize activated forms
of SFKs, anti-phosphotyrosine antibody (clone 4G10, Upstate, Lake
Placid NY, USA), α and β tubulin (Sigma). All of these were mouse
monoclonal antibodies. YOL 1/34 rat monoclonal α tubulin (Abcam,
Cambridge MA). Secondary antibodies were Alexa 488 or Alexa 568
(goat anti-mouse or goat anti-rat depending on the source of the
primary antibody; Molecular Probes, Eugene OR). Oocytes were
labeled with primary antibodies at 35 °C for 1 h or overnight at 4 °C
followed by secondary antibody for 1 h. After secondary labeling,
oocytes were transferred to a wash solution containing 1 μg/ml
Hoechst 33258with orwithout 1:100 Alexa 568-phalloidin and stored
in the dark overnight at 4 °C. Oocytes and COC were mounted the
following morning and imaged (mounting medium consisted of 1:1
glycerol: PBS supplemented with 5 mg/ml sodium azide and 1 μg/ml
Hoechst 33258). All chemicals, hormones and reagents were pur-
chased from Sigma Chemical Company, St. Louis, MO unless otherwise
stated.
siRNA knock-down of FYN PTK
COC were collected in mFHM supplemented with 300 μM cAMP to
prevent GVBD. Most of the cumulus cells were removed by brief
exposure to 0.3 mg/ml hyaluronidase and gentle pipetting with a ﬁne
glass pipet. FYN siRNA (Santa Cruz #sc-35425) and a 20–25 nt non-
targeting scrambled control siRNA (Santa Cruz #sc-37007 and sc-
36869) were prepared with supplied diluent at a concentration of
100 μM. Immediately before injections, siRNA was thawed and
centrifuged at 16,000 g for 10 min at 4 °C then back loaded into
0.3 μm Egg-Jek needles (MicroJek, Kansas City, KS). Injections were
performed on an inverted Nikon Eclipse TE2000-S with an Eppendorf
FemtoJet injection system. Preliminary studies were conducted to
determine the optimum siRNA concentration. Three concentrations
were tested including, 0.7, 1.40 and 2.8 μM. At 2.8 μM, control siRNA
caused a reduction in the percentage of oocytes maturing to MII
therefore this concentration was considered too high. The lower two
concentrations of the control siRNA produced no measurable inhibi-
tion of maturation therefore 1.4 μM was selected for use in these
studies. Following completion of siRNA microinjections, oocytes were
transferred to Terasaki plates and culture for 4–5 h in KSOM-MAT
supplemented with 300 μM cAMP to maintain GV arrest and to allow
for siRNA inhibition of endogenous mRNA. Oocytes were examined at
the beginning and end of this culture and graded for the presence of a
Fig. 1. Activated SFKs distribute in microtubule-like patterns at the GV, MI and MII
stages of meiosis. Germinal vesicle stage oocytes were collected from eCG primed
mouse ovaries and matured in vitro for 0, 8 or 16 h followed by ﬁxation. Oocytes were
labeled with amonoclonal antibody against activated SFKs (clone 28) and detectedwith
Alexa-488-goat anti-mouse IgG (white) and co-labeled with the DNA dye Hoechst
33258 (red). Active SFKs are distributed in microtubule-like patterns consistent within
oocytes and companion cumulus cells; see mitotic spindle microtubule labeling in
cumulus cell (GV inset). Within GV stage oocytes, SFKs localized to cytoplasmic
microtubule arrays surrounding the nuclear envelope as well as cortical microtubule
organizing centers (⁎). At MI and MII, SFKs localize primarily to microtubules of the
metaphase spindle.
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andmatured 17 h in KSOM-MAT. The selective knock-down of Fynwas
examined by semi-quantitative RT-PCR for both Fyn and Yes kinases.
Semi-quantitative RT-PCR
Groups of 10 oocytes (Fyn siRNA, control siRNA and non-
injected) were dissolved into 500 μl of TRIzol-Reagent (Invitrogen)
and stored at −80 C. A known concentration of Rabbit αGlobin
mRNA was added to each tube of oocytes (1.0 pg/oocyte) in
TriReagent. The methods for cDNA preparation and RT-PCR were as
previously published (Barrett and Albertini, 2007). Primers for Fyn
and Yes kinases were generated using Primer Express 2.0 from
Applied Biosystems (Fyn5′AGT GCC ATA CCC AGG CAT GA; Fyn3′GTG
GGC AGG GCA TCC TAT AG; Yes5′GCT TCC ACA GCT GGT TGA TAT G;
Yes3′AGA TCT CGG TGA ATA TAG TTC ATT CTT TC; Integrated DNA
Technologies, Coralville IA). Relative levels of mRNA as determine by
RT-PCR were statistically compared by t-test. P-value of less than
0.05 was considered signiﬁcant.
Imaging and data analysis
Oocytes were imaged by serial z-sections (1–2 μm depth) on a
Zeiss LSM510 confocal microscope. Serial z-sections were used to
establish 3-dimensional relationships between the oolema, chroma-
tin, meiotic spindle, ﬁrst polar body and companion cumulus cells.
Statistical analysis of meiotic maturation was performed using SPSS
software (SPSS Inc., Chicago IL). Data were analyzed by ANOVA
followed by Bonferonni post-hoc comparisons for experiments with
3 or more treatments. P-value of less than 0.05 was considered
signiﬁcant.
Results
Activated Src-family kinases localize to microtubules in mouse oocytes
throughout meiotic maturation
Previous work had demonstrated that activated SFKs were
concentrated in close association with microtubules of meiotic
spindles in MII oocytes (McGinnis et al., 2007). While Fyn kinase
has been shown to localize in the region of premetaphase spindle
(Talmor-Cohen et al., 2004b), the speciﬁc association of activated SFKs
to microtubules at the germinal vesicle stage oocyte has not been
demonstrated (Zheng et al., 2007). Therefore, as an initial step we
sought to determine the localization of activated SFKs during the early
stages of meiotic maturation. To accomplish this, we used a
phosphorylation site-speciﬁc antibody (clone 28) that recognizes
the activated (dephosphorylated) Y527 in the carboxyl tail region of
Src-family proteins (Kawakatsu et al., 1996). Epitope distribution was
determined by confocal ﬂuorescence microscopy in oocytes ﬁxed
following 0, 8 and 16 h of in vitro maturation as seen in Fig. 1. In
germinal vesicle stage immature oocytes, clone 28 staining was
observed in a pattern that has been associated with cytoplasmic
microtubules that surround the GV (Messinger and Albertini, 1991) as
well as those emanating from cortical microtubule organizing centers
(⁎ MTOCs; Fig. 1 GV). Clone 28 also labeled cumulus cells associated
with the zona pellucida with staining being disposed along the
cumulus cell surface and throughout the cytoplasm. Mitotic ﬁgures
are commonly seen in the cumulus and in dividing cells, a prominent
spindle labeling was readily apparent (Fig. 1, insert). In oocytes at
metaphase of meiosis-I or II (Fig. 1 MI and MII), activated Src-family
PTKs were distributed throughout the meiotic spindles in a pattern
not unlike that seen in our previous study of MII oocytes (McGinnis et
al., 2007). These ﬁndings clearly indicate that the clone 28 epitope is
speciﬁcally expressed in a microtubule-associated pattern throughout
all stages of oocyte maturation in mouse oocytes.Chemical inhibition of Src-family kinases during meiotic maturation
causes a dose dependant failure of progression through metaphase of MI
To determine whether meiotic progression requires SFK activity,
cumulus enclosed or denuded oocytes were matured in the presence
of the inhibitor, SKI606. COC collected from ovaries of eCG primed
mature CF1 female mice were released directly into media containing
1, 5 or 10 μM SKI606 or the solvent DMSO as a control. SKI606 is a new
and highly selective inhibitor of Src-family kinases and the closely
related Abl kinases (Boschelli et al., 2004, 2001) and has been used
previously in studies of SFK activities in mouse zygotes (McGinnis et
al., 2007). The three concentrations of SKI606 were selected on the
basis of preliminary dose response experiments (not shown) and our
previously published studies with pronuclear stage zygotes (McGinnis
et al., 2007). SKI606 had no effect on the ability of oocytes to resume
meiosis (GVBD 75–100% in all groups), however, maturation through
metaphase-I was signiﬁcantly reduced as seen in Fig. 2A. Exposure of
either denuded oocytes (Egg) or cumulus enclosed oocytes (COC) to
concentrations of SKI606 at 5 μMor greater caused approximately 50%
maturation failure. Oocytes that were enclosed by cumulus exhibited a
similar response to SKI606. Oocytes matured in the continuous
presence of the SFK inhibitor and progressed to metaphase-II
exhibited marked defects in spindle and chromatin organization
(Fig. 2B). Notably at 5 and 10 μM concentrations, all of the oocytes that
matured to MII in the presence of SKI606 were distinctly abnormal as
detailed below. The effect of SKI606 was reversible (Table 1) since
oocytes exposed to the inhibitor for 5 h followed bywash-out and 17 h
of culture progressed to MII at a frequency that was 87% of that
observed in controls (PN0.05).
Inhibition of Src-family kinases during meiosis results in spindle and
chromosomal abnormalities
To ascertain how SFK inhibition was inﬂuencing meiotic progres-
sion, confocal microscopy was performed on control and treated
oocytes matured under the conditions described above. While
phalloidin (f-actin) staining failed to reveal major changes in actin
Fig. 3. Inhibition of Src-related kinases with SKI606 induced abnormal spindles and
misalignment of chromosomes during meiosis. Denuded oocytes (Eggs) and intact COC
matured 17 h in 0, 1, 5 or 10 μM SKI606 (Fig. 2) were ﬁxed and co-labeled with
monoclonal mouse anti-αβ tubulin (microtubules; green) and goat anti-mouse Alexa-
488, phalloidin-Alexa-568 (f-actin; red) and Hoechst 33258 (DNA; white) and oocytes
were confocal imaged and examined as described previously. Three-dimensional
reconstructions were used to examine oocyte meiotic status and the associations of
tubulin, actin and DNA. The majority of control oocytes (A=0 μM SKI606) matured and
arrested at metaphase of meiosis II with normal spindle morphology, chromatin aligned
on the metaphase plate and an extruded polar body. Oocytes exposed to SKI606
arrested at various stages of meiosis, many with displaced chromosomes and spindle
microtubules that branch abnormally in seeming attempts to enclose these aberrant
chromosomes (B–H). Fewer abnormal oocytes occurred in the lower doses of SKI606 as
compared to the higher doses, however the general types of abnormalities were the
same across all concentrations of the inhibitor (malformed spindles and wayward
chromosomes: B, C, G=10 μM; D, E, F=5 μM; H=1 μM SKI606, respectively). Panels E
(tubulin label turned-off) and F (with tubulin (green)) are the same oocyte. Both images
are shown to demonstrate the stretched chromosomes that failed to separate (E) even
though the spindle microtubules have attempted to elongate and undergo anaphase (F).
Panel H demonstrates two oocytes cultured in low (1 μM) SKI606 which extruded polar
bodies but have displaced chromosomes. One oocyte has a chromosome that failed to
Fig. 2. Chemical inhibition of SFKs during maturation reduces meiotic potential and
induces metaphase chromosome alignment and spindle errors. COCwere released from
the ovaries of eCG primed female CF1 mice at 40 h post-eCG then cultured in KSOM-
MAT medium supplemented with SFK inhibitor SKI606 for 17 h. The concentration
range of 0–10 μM chosen was based on previous studies (McGinnis et al., 2007). (A)
Inhibition of SFKs blocked meiosis at metaphase-I in a dose dependant manner in both
cumulus intact (COC) and denuded oocytes (Egg). No signiﬁcant effect on the number of
oocytes that underwent GVBD (black bars) was observed. However, maturation to
metaphase-II (white bars) was inhibited. Cumulus-enclosed oocytes were more
sensitive to inhibitor, with none maturing to MII in the 10 µM dose and maturation
in 5 μM (**) being signiﬁcantly lower than 1 μM or 0 μM (Pb0.05). The ability for
denuded oocytes to mature was also dose dependant with signiﬁcantly fewer oocytes
maturing to meiosis II in medium with 10 μM as compared to 0 or 1 μM. (B) SKI606
treated oocytes that progressed to metaphase II exhibited chromosome and spindle
abnormalities. Of those oocytes that progressed to metaphase II in 5 or 10 μM (⁎)
SKI606, 100% were abnormal as compared to the 1 and 0 μM concentrations.
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range of defects in chromatin and microtubule disposition (Fig. 3).
Control oocytes matured to metaphase-II exhibited extruded polar
bodies and chromosomes aligned on a bipolar meiotic spindle
(Fig. 3A). SKI606 induced abnormalities that appeared to reﬂect
disruption of the interactions between chromosomes and spindle
microtubules. For example, displaced chromosomes were found onMI
(Figs. 3B, G) or MII spindles (Fig. 3H⁎⁎) and in many cases bivalent
segregation failed to occur at anaphase or telophase of MI (Figs. 3B,
E–F). Thus, MI stage oocytes entered anaphase without disengaging
homologues as evidenced by the presence of elongated anaphaseTable 1
The short-term exposure inhibitory effects of SKI606 are reversible
Exposure time N %GVBD %MII
5 h DMSO 12 100 100
5 h SKI 35 80 87
Treated oocytes matured through GVBD to metaphase-II at rates similar to controls
(PN0.05).
segregate and was trapped in the constriction site between the polar body and the
oocyte (⁎) while the second oocyte has multiple chromosomes displaced along the
spindle (⁎⁎) [scale bar=10 μm].spindles contained unresolved bivalents along nearly the entire length
of the spindle (Figs. 3E, F). Telophase oocytes also exhibited lagging
chromosomes trapped within the contractile ring of forming polar
bodies (Figs. 3D, H⁎). In addition to the positioning of chromosomes,
SKI606 induced a variety of severe spindle aberrations during meiosis.
Many spindles were loosely organized and irregular in shaped, exten-
Table 2
Precocious meiotic resumption of oocytes cultured with Src inhibitor SKI606
Exposure time N %GVBD %MII
5 h cAMP 10 0a 100c
5 h SKI606+cAMP 43 60b 93c
Oocytes cultured with the Src inhibitor and dbcAMP resumed meiosis and initiated
GVBD while control oocytes remained arrested at GV (a,b) PN0.05. Following wash-out
from the dbcAMP both control and SKI606 treated oocytes matured to MII (c) PN0.05.
Fig. 4. Microinjection of Fyn siRNA signiﬁcantly reduced levels of Fyn mRNA. Oocytes
injectedwith Fyn siRNAwerematured 17 h then pooled in sets of 10 and tested by semi-
quantitative RT-PCR for levels of Fyn mRNA and the closely related Yes mRNA. Injection
of Fyn siRNA resulted in a signiﬁcant (∼80%; ⁎Pb0.05) knock-down of Fyn mRNA as
compared to scrambled control siRNA injected and non-injected oocytes (A). Fyn siRNA
had no effect on the levels of Yes kinase mRNA (B) (n=4, 2, 4 replicates, respectively).
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Some oocytes exhibited segregated chromosomes in anaphase, but
failed to extrude a polar body (Fig. 3C). In such cases, oocytes with two
spindles were formed, one of which was monopolar and the other
being bipolar. In the example shown here (Fig. 3C), the monopolar
spindle was attached to a single pole of the bipolar spindle. However,
this characteristic was not consistent for all oocytes that failed to
complete cytokinesis. In most cases, bipolar and monopolar spindles
were completely separate entities. Monopolar spindles displayed
microtubule bundles that extended up to and along the oolema (not
shown). Cortical actin localization appeared normal: As has com-
monly been seen, chromatin subjacent to the oolema was associated
with cortical f-actin caps (Figs. 3E–G) and f-actin density was
increased in cortical regions involved in cytokinesis and the polar
body extrusion (Fig. 3D). The abnormalities observed after continuous
exposure to SKI606 indicate that while spindle morphogenesis
following GVBD appeared to occur on schedule relative to controls,
treated oocytes are impaired in their ability to support chromosome
segregation during the metaphase–anaphase transition of meiosis-I.
Src-family kinases are required for maintenance of meiotic arrest
In the above inhibitor study, it was noted that oocytes exposed
to SKI606 tended to undergo GVBD earlier than controls suggesting
that meiotic resumption might be accelerated by this treatment. To
further test this with better meiotic synchrony, we cultured
immature oocytes with 300 μM dbcAMP which has been shown
to prevent GVBD for up to 6 h even in the presence of the
maturation stimulators FSH and EGF (Downs and Chen, 2008). Thus,
to establish whether SFKs participate in maintenance of meiotic
arrest, we cultured oocytes in KSOM-MAT (FSH and EGF supple-
mented media) with 300 μM dbcAMP with or without 10 μM SKI606
for 5 h, washed samples in drug free medium, and allowed
maturation to proceed for 17 h (in the absence of dbcAMP).
Following wash-out and IVM, both control and SKI606-treated
oocytes matured to normal metaphase-II (93% with SKI606 versus
100% controls, Table 2) conﬁrming the reversibility of SKI606.
However, inhibition of SFKs in the presence of dbcAMP either
permitted or induced the resumption of meiotic maturation within
5 h of treatment (60% GVBD with SKI606 versus 0% controls)
suggesting that SKI606 sensitive kinases may participate in GV
arrest.
Injection of FYN siRNA into GV stage oocytes demonstrates a speciﬁc
requirement for Fyn kinase during meiotic maturation
One drawback of the pharmacological approach described above
is that SKI606 inhibits the activity of all members of the Src-family
and Abl-family kinases. Since FYN kinase is the most highly
expressed of the Src-family members in mouse oocytes (Novartis
Mouse Gene Atlas; https://biogps.gnf.org), we sought to more
speciﬁcally test the role of Fyn kinase in oocyte maturation.
Mouse oocytes arrested at the GV stage using dbcAMP were injected
with either FYN siRNA or a 20–25 nt non-targeting control siRNA.
Following injections, oocytes were cultured for 4–5 h in complete
maturation medium supplemented with 300 μM dbcAMP to prevent
resumption of meiosis and to allow time for depletion of FYNmRNA. GV stage oocytes were then washed free of dbcAMP and
matured in vitro for 17 h. After 17 h of culture, oocytes were ﬁxed
and labeled for tubulin, actin and DNA for confocal microscopy as
above. To conﬁrm the knock-down and speciﬁcity of the Fyn siRNA,
sets of 10 oocytes were pooled after 17 h of culture and tested for
mRNA levels of Fyn and Yes kinases. Yes kinase is a Src-family
member closely related to Fyn and is the second highest expressed
of the SFKs in mouse oocytes (Novartis Mouse Gene Atlas; https://
biogps.gnf.org). Kinase mRNA levels were normalized against a
known concentration of rabbit alpha-globin mRNA. The Fyn siRNA
caused a signiﬁcant (∼80%, Pb0.05) decrease in Fyn mRNA as
compared to scrambled control siRNA injected or non-injected
oocytes (n=4, 2 and 4 replicates, respectively; Fig. 4A). There was no
difference in the level of Fyn mRNA between control siRNA injected
versus non-injected oocytes and no effect of Fyn siRNA on the levels
of Yes kinase demonstrating the speciﬁcity of the Fyn knock-down
(Fig. 4B).
Oocytes injected with FYN siRNA undergo GVBD but exhibited a
reduced capacity to progress to metaphase-I (83% versus 100% of
controls; Pb0.05, Fig. 5). Few oocytes were able to mature to
metaphase-II (39% versus 86%; Pb0.05). Injection of FYN siRNA did
not induce premature resumption of meiosis in the presence of
dbcAMP nor were overt chromatin or spindle organizational defects
observed (not shown). The selectivity of FYN siRNA relative to controls
implies a direct role for FYN in meiotic progression of mouse oocytes.
To further test this, we next examined the phenotypes of oocytes
collected from FYN knockout animals.
Fig. 6. Superovulated FYN (−/−) oocytes exhibit misaligned chromosomes. Oocytes were
collected fromsuperovulated FYN (−/−) andwildtype controlmice 16hpost-hCG. Control
mice ovulatedmetaphase-II stage oocytes,110/111, 99%,whereas only 85% (58/68) of FYN
(−/−) had reached metaphase-II. Analysis of cytoskeleton and chromatin organization
showed normal chromosome alignment in 99% of control MII oocytes (B6/129), however
19% of the MII and 6% of MI stage FYN (−/−) oocytes exhibited misaligned chromosomes.
Differential interference contrast (DIC) images of ovulated oocytes from B6/129 control
mice (MII) and FYN KO (−/−) mice (MI) labeled with DNA dye Hoechst 33258 (white).
Fig. 5. Fyn PTK activity is required for meiotic maturation of mouse oocytes. Oocytes
injected with FYN siRNA were held arrested at the GV stage in 300 μM cAMP for 4–5 h,
washed in cAMP-free media, and cultured in maturation media for 16–17 h. Controls
included injection with an equal concentration of scrambled control siRNA or
processing in the above solutions without injection. Seven replicates with siRNA were
conducted using both types of controls. Oocytes were labeled for microtubules and DNA
as described above (Fig. 3) and scored to determine meiotic stage. Injection of FYN
siRNA into GV stage oocytes signiﬁcantly decreasedmeiotic maturation since fewer FYN
siRNA oocytes reached metaphase of MI compared to control siRNA injected or non-
injected oocytes (83% versus 100% and 100%, respectively; ⁎Pb0.05). Maturation to MII
was also impaired with only 39% of FYN siRNA injected oocytes reaching metaphase-II
as compared to control siRNA and non-injected oocytes (86% and 93%, respectively;
⁎⁎Pb0.05).
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and spindle organization
To further examine the role of Fyn kinase during oocyte meiotic
progression, we compared oocyte maturation of normal and FYN (−/−)
mice both in vivo and in vitro. Mature females were superovulated
and oocytes were collected from oviducts 16 h post-hCG. The total
number of oocytes ovulated by FYN (−/−) females were not different
from control females (17 and 22, respectively; Table 3). While all
ovulated oocytes isolated fromboth FYN (−/−) and control animals had
undergone GVBD (68 and 111 oocytes, respectively), only 85% (58/68)
of oocytes from FYN (−/−) animals had matured to metaphase-II
compared to 99% (110/111) of controls (Pb0.05%). Moreover, ovulated
FYN (−/−) oocytes exhibited a slightly higher percentage of spindle and
chromosome alignment abnormalities relative to controls (19% (11/
58) versus 4% (4/110), respectively) although this difference was not
statistically signiﬁcant. The types of abnormalities detected in oocytes
from Fyn (−/−) animals were associated with chromosome alignment
and meiotic spindles (Fig. 6). Since ovulated FYN (−/−) oocytes
exhibited reduced maturation, we next tested maturation using our in
vitro culture system. This provided a more consistent controlled
environment under which the maturation competence of FYN (−/−)
oocytes could be ascertained without in vivo variability due to
endocrine and/or ovarian factors.
FYN knock-out mice exhibit a meiosis-I defect
Fully grown oocytes (with or without cumulus cells) were
collected from the ovaries of mature females at 44 h post-eCG similar
to previous experiments. More oocytes from antral follicles were
obtained from FYN (−/−) mice (n=3) as compared to normal control
females (n=4; 53 oocytes versus 26 oocytes per donor, respectively).
COC from FYN (−/−) mice matured in vitro for 16 h exhibited cumulusTable 3
FYN (−/−) mice ovulate oocytes with meiotic progression defects
Strain # Donors # Oocytes %GVBD %MII % Abnormal MII
B6/129 5 111 100 99a 4c
Fyn (−/−) 4 68 100 85b 19c
All ovulated oocytes initiated GVBD. A signiﬁcant percentage of ovulated FYN (−/−)
oocytes failed to reach metaphase-II and were blocked at metaphase-I (a,b) Pb0.05.
There was a tendency for FYN (−/−) oocytes to exhibit abnormal spindle and chromatin
alignment however this difference was not statistically signiﬁcant (c) PN0.05.expansion similar to wildtype controls indicating that cumulus cell
expansion is not inﬂuenced by the loss of Fyn.
The ability of FYN (−/−) oocytes to mature in vitro was signiﬁcantly
reduced compared to controls. FYN (−/−) oocytes progressed through
GVBD but arrested at various stages between GVBD and metaphase-I.
Only 20% (32/158) of FYN (−/−) oocytes matured to metaphase-II as
compared to 49% (51/105) of controls (Fig. 7). Of those oocytes from
FYN (−/−) females that matured to metaphase-II, 22% of these (7/32)
exhibited abnormal spindle formation and/or chromosome misalign-
ment compared to only 4% (2/51) of controls although this difference
was not statistically signiﬁcant. FYN (−/−) oocytes that blocked at
metaphase-I also demonstrated spindle and chromosome alignment
errors but at a low incidence (5/78, 6%). No cytoskeletal defects were
observed inmetaphase-I arrested oocytes from control animals (0/31).
The errors observed in FYN (−/−) oocytes resembled those identiﬁed in
our earlier chemical inhibitor studies with misaligned chromosomes
and malformed spindles. Thus, three distinct experimental strategies
including biochemical inhibition of Src-related kinases, as well as
siRNA knock-down, and gene knockout of Fyn kinase have yielded
results consistent with a role for SFKs in meiotic progression,
chromosome segregation and spindle function in mouse oocytes.
Discussion
Oocytes prepare for fertilization and later development by under-
going a programmed series of maturational events in response to an
ovulation-inducing surge of LH. At the level of the ovarian follicle,Fig. 7. Oocytes from FYN (−/−) mice exhibit reduced meiotic potential. Oocytes and COC
from FYN (−/−) and wildtype controls collected at the GV stagewerematured in vitro for
16 h and subjected to ﬂuorescence analysis as before. FYN (−/−) oocytes exhibited
reduced meiotic potential as indicated by the fact that while FYN (−/−) oocytes
underwent GVBD to comparable levels as wildtype controls (70% versus 76%,
respectively), signiﬁcantly fewer FYN (−/−) oocytes achieved MII (20% versus 49%;
⁎⁎Pb0.05).
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ovulation that ensure the coordinate induction of ovum release,
cumulus expansion and oocyte maturation. Amongst these signaling
pathways, SRC, RAS, and EGF have all been implicated in the terminal
differentiation of granulosa cells (Fan et al., 2008; Shiota et al., 2003;
Wayne et al., 2007) and preliminary reports have invoked a role for
SFKs within the oocyte itself with reference to meiotic maturation and
egg activation (McGinnis et al., 2007; Mehlmann and Jaffe, 2005;
Meng et al., 2006; Talmor-Cohen et al., 2004a; Zheng et al., 2007).
The present studies aimed to better deﬁne the activities of SFKs
during meiotic maturation in mouse oocytes by taking advantage of
the experimental tractability of this model system. A series of in
vitro maturation experiments showed that SFKs function in meiotic
progression through the metaphase–anaphase transition of meiosis-
I with the most prominent defects being a failure to segregate
homologous chromosomes. From pharmacological inhibition, FYN
siRNA knockdown, and the use of FYN knockout mice, resolution of
bivalents and progress to metaphase-II appears to require the
activity of SFKs, and in particular FYN kinase. The fact that genetic
depletion of FYN kinase activity caused a similar series of meiosis
defects both in vivo and in vitro, involving failure of chromosome
disjunction during anaphase and abnormal organization of spindle
microtubules, suggests that FYN assists in the coordination of
karyokinesis and cytokinesis during meiotic maturation and that
additional effectors such as other SFKs are likely to integrate
meiotic cell cycle progression in this system. Fyn (−/−) mice are
viable but females produce only 2–3 litters after which reproduc-
tion fails (Kinsey lab records). Interestingly, histological examina-
tion of ovaries following superovulation found antral follicles in Fyn
(−/−) females that failed to ovulate (not shown). This may explain
the disparity in the number of oocytes obtained between our in
vitro maturation studies where oocytes are manually extracted
from all antral follicles as compared to ovulated oocytes retrieved
from the oviducts. Fyn (−/−) ovaries yielded far more oocytes than
wildtype ovaries and a major proportion of the Fyn (−/−) oocytes
were incapable of normal oocyte maturation, while the super-
ovulated oocytes retrieved from the oviducts were more similar
between the Fyn (−/−) and control animals. Studies are currently
ongoing in our laboratory to better deﬁne these issues in the
knock-out mouse.
The mechanism of Fyn action in chromosome segregation and
spindle function may involve its close association with spindle
microtubules. Previous studies on rat oocytes demonstrated
localization of Fyn kinase to microtubule-containing structures
(Talmor-Cohen et al., 2004b; Talmor et al., 1998). The fact that FYN
is the most highly expressed SFK in mouse oocytes (Genomics
Institute of the Novartis Research Foundation (“GNF”), https://
biogps.gnf.org (Su et al., 2002)), together with our earlier ﬁnding
that activated SFKs were associated with spindle structures after
fertilization (McGinnis et al., 2007) led us to further deﬁne the
functional signiﬁcance of this association during oocyte maturation.
The results presented here indicated that this spindle-associated
Fyn is highly active since it was detected with the Clone 28
antibody. This association with microtubules continued during
spindle morphogenesis following GVBD and persisted within
spindles throughout meiotic maturation. Activated SFK localization
was also maintained with MTOCs at all stages consistent with
previous studies using pericentrin and MPM2 which demonstrated
Ser/Thr phospho-proteins associated with MTOCs throughout
meiotic maturation (Messinger and Albertini, 1991). Talmor et al.
(1998) ﬁrst demonstrated the co-localization of Fyn kinase to the
meiotic spindle in mammalian oocytes and later proved the
association of Fyn with tubulin in co-immunoprecipitation assays
(Talmor-Cohen et al., 2004b). We have now demonstrated activated
Src-family kinases associate with meiotic spindles and cytoplasmic
microtubules at all stages of meiosis.SFKs in general and Fyn in particular are known to be involved in
somatic cell mitotic cell cycle progression (Roche et al., 1995; Thomas
and Brugge, 1997). Direct interactions of Fynwith dynein (Campbell et
al., 1998) and γ-tubulin (Kukharskyy et al., 2004; Sulimenko et al.,
2006) have been proposed as responsible for mitotic arrest and
microtubule stability in a variety of mammalian cell types (Moasser et
al., 1999). In the mammalian oocytes, γtubulin is involved in spindle
positioning and size (Barrett and Albertini, 2007). Together with our
current results this suggests a possible relationship between Fyn
kinase signaling and γ-tubulin in the regulation of themeiotic spindle.
Moreover, the presence of monopolar spindles and displaced
chromosomes further implies that as yet unresolved forces exerted
during bivalent attachment to the spindle may be under the local
control of Src-related kinases integrated into the meiotic spindle.
We have also shown that inhibition of Src-related kinases with the
chemical inhibitor SKI606 and siRNA of Fyn kinase prevented the
progression of meiosis fromMI to metaphase-II. This ﬁnding contrasts
those reported by Zheng et al. (2007) in which mouse oocytes
matured in the presence of the SFK inhibitor (PP2) were unable to
undergo GVBD. Our studies using the inhibitor SKI606 did not reveal a
signiﬁcant inhibitory effect on GVBD. In fact, we found that under
meiosis arresting conditions, this drug induced the resumption of
meiosis (Table 2). The variance in the results of Zheng et al. (2007) and
this work may be due in part to differences in the speciﬁcity or action
of the inhibitors. For example, SKI606 represents a new generation of
quinolinecarbonitrile derivatives with high speciﬁcity for SFKs
(Boschelli et al., 2004). This compound inhibits Src in vitro with an
IC50 of 1.2 nM, while having low afﬁnity for other kinases such as
receptor protein tyrosine kinase ErbB-2 (IC50 of 2.6 μM) and Ser/Thr
kinase Cdk4 (IC50 of 19 μM) (Boschelli et al., 2001). The afﬁnity of
SKI606 is similar between Src and other family members such as Fyn
(Boschelli et al., 2001). The Src inhibitor PP2 has an in vitro IC50 of
5 nM for Fyn kinase (Hanke et al., 1996). Like PP2 (Clark and Peterson,
2003), SKI606 also inhibits the Src-related Abl kinase with an in vitro
IC50 of 1.0 nM. While the general activities of SKI606 and PP2 are
similar, slight differences in afﬁnity and selectivity may account for
the varied effects reported here and elsewhere. More likely, variations
in chemical inhibitor results may take their origins in IVM culture
protocols and/or differences in mouse strains used since mouse strain
variations have been reported for both in vivo and in vitro matured
oocytes (Ibanez et al., 2005a,b). Additionally, Zheng et al.(2007)
cultured naked oocytes in basal M2 medium without supplementa-
tion. While basal salt media allow for spontaneous meiotic resump-
tion of cultured oocytes from many mammalian species (Edwards,
1965), these conditions are inadequate for production of oocytes of
high developmental potential (Eppig et al., 2000). In our studies we
used a modiﬁed KSOMAA medium supplemented with factors
designed to induce meiotic maturation and cumulus expansion
(FSH, EGF, cysteine, glucosamine and ascorbic acid; see Materials
and methods section). FSH and EGF are known activators of SFKs in
somatic and granulosa cells (Cottom et al., 2003; Wayne et al., 2007),
therefore media containing these hormones may activate signaling
pathways during meiotic maturation that are not operative in a basal
salt medium.
In summary, the suppression of Fyn activity caused defects in
spindle organization and chromosome segregation that in some cases
broughtmeiotic maturation to a halt whereas in other cases permitted
advancement of the cell cycle to metaphase-II albeit with signiﬁcant
distortions in the spindle. The lack of complete penetrance as seen in
oocytes from FYN (−/−) animals, implies some level of redundancy in
function for ovarian SFKs.
Taken together, these results suggests that the primary active Src-
family kinase associated with the spindle of the mammalian oocyte is
Fyn and that disruption of Fyn kinase leads to failure of meiotic
maturation by disrupting the cell cycle dynamics of spindle and
chromosome organization.
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